Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

STD-HIV AIDS 2018

About the Conference

Conference Series LLC is hereby pleased to invite all the participants from all over the world to attend the “6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs” going to be held on October 29-30, 2018 at Madrid, Spain. The conference includes prompt presentations, special sessions, workshops, symposium, oral talks, poster presentations and exhibitions. We expect your kind presence at the conference which will discuss and sharing their knowledge and research in the field of HIV/AIDS, STDs, STIs and other infectious diseases which have become progressively important to Public Health.

Why to Attend?

STD-HIV/AIDS-2018 highlights the theme “Enhance competency in HIV Prevention and Care” Which focuses knowledge and research in the field of HIV/AIDS, STDs, STIs and other infectious diseases which have become progressively important to Public Health.

 

STD-HIV/AIDS-2018 provides two days discussions on methods and strategies related to Control and Prevention of HIV/AIDS, STDs & STIs as well as explore new ideas and concepts on a global scale. This two day event provides a perfect platform for leading scientists, researchers, scholars, practitioners, health care experts, treatment providers, public health professionals, community health educators, members of academia, and other allied health professionals.  Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, and Social Workers, academia, students, researchers, faculty, STD-AIDS associations and societies.

The target audience for this event are physicians and nurses with a special emphasis on infectious diseases, public health professionals, community health educators, members of academia, and other allied health professionals.  Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, and Social Workers, academia, students, researchers, faculty, STD-AIDS associations and societies.

Conference Series Ltd is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80000 editorial board members and 7.5 million followers to its credit. Conference Series is an open resource platform that conducts 3000+ global events including International Conferences, Workshops, Symposia, Trade Shows, Exhibitions and Science Congresses in all the major scientific disciplines, including Clinical, Medical, and pharmaceutical, Engineering, Technology, Business Management and Life Sciences across America, Europe, The Middle East, and Asia Pacific.

Other Reasons:

  • World Class Speakers and Fresh New Talent from across the Globe in Health Industry
  • Packed Schedule: Workshops, Multi-track Conference, Expo area and more...
  • To educate yourself on the diagnosis and treatment of STD and Infectious diseases.
  • To enhance your ability to treat the growing number of patients affected by these diseases.
  • To network with your fellow primary care clinicians.
  • To empower yourself to fill the void created by the national shortage of participants.

Targeted audience-

·         Microbiologists

·         Bacteriologists

·         Virologists

·         STD-AIDS associations and societies

·         Epidemiologists

·         Health care professionals

·         Research scholars

·         Medical colleges

·         Infectious Diseases Researchers

·         Viral Diseases Researchers

 

Acquired Immuno Deficiency Syndrome is a syndrome caused by a virus called HIV (Human Immunodeficiency Virus). The disease alters the immune system, making people much more vulnerable to infections and diseases. This susceptibility worsens as the syndrome progresses.

HIV is found throughout all the tissues of the body but is transmitted via the body fluids of an infected person (semen, vaginal fluids, blood, and breast milk).

HIV is the virus, which attacks the T-cells (CD-4 cells) in the immune system. AIDS is the syndrome, which appears in the advanced stage of HIV infection. HIV infection can cause AIDS to develop. Without treatment, the HIV infection can progress and, eventually, it will develop into AIDS in the vast majority of cases. Once someone has received an AIDS diagnosis, it will always carry over with them in their medical history.

 

 For Scientific Sessions please go through the link: http://std.conferenceseries.com/call-for-abstracts.php

 For Abstract Submission please go through the link: http://std.conferenceseries.com/abstract-submission.php  

Sessions/Tracks

Track 1: HIV/AIDS

HIV stands for Human immunodeficiency virus. It harms your immune system by destroying the white blood cells that fight infection. This puts you at risk for serious infections and certain cancers. AIDS stands for Acquired Immuno Deficiency Syndrome. It is the final stage of infection with HIV. Not everyone with HIV develops AIDS. People affected by this virus will be susceptible to opportunistic infection or susceptible to tumors. AIDS is the most severe phase of HIV infection.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: AIDS Research Institute, San Francisco, CA; International AIDS Society, Switzerland; National AIDS Commission of Belize, Belize; St. Maarten AIDS Foundation, Cole; HIV.gov, Washington; HIV Medicine Association, Arlington; National Association of People Living With HIV/AIDS, South Africa; BHIVA, UK.

Track 2: HIV Prevention

The best way to prevent HIV and other sexually transmitted infections (STIs) is to use a condom for penetrative sex and a dental dam for oral sex. The best way to prevent HIV is to use a condom for sex and to never share needles or other injecting equipment (including syringes, spoons and swabs).

To help prevent the spread of HIV

  • Take antiretroviral medicines. Getting treated for HIV can help prevent the spread of HIV to people who are not infected.
  • Tell your sex partner or partners about your behaviour and whether you are HIV-positive.
  • Follow safer sex practices, such as using condoms.
  • Do not donate blood, plasma, semen, body organs, or body tissues

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; American Sexual Health Association, North Carolina; National AIDS Control Organisation, India; AIDS Society of India; Canadian AIDS Society, Canada; Southern African HIV Clinicians Society, South Africa. DESIRE Society Inc, United States. UNAIDS, Switzerland.

Track 3: Sexually transmitted diseases

Sexually Transmitted Diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses. There are more than 20 types of STDs. Most STDs affect both men and women, but in many cases the health problems they cause can be more severe for women. If a pregnant woman has an STD, it can cause serious health problems for the baby.

Antibiotics can treat STDs caused by bacteria, yeast, or parasites. There is no cure for STDs caused by a virus, but medicines can often help with the symptoms and keep the disease under control. Correct usage of latex condoms greatly reduces, but does not completely eliminate, the risk of catching or spreading STDs.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: AIDS Research Institute, San Francisco, CA; International AIDS Society, Switzerland; National AIDS Commission of Belize, Belize; St. Maarten AIDS Foundation, Cole; UNAIDS, Switzerland; HIV.gov, Washington; HIV Medicine Association, Arlington; BHIVA, UK; National Association of People Living With HIV/AIDS, South Africa; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; American Sexual Health Association, North Carolina; National AIDS Control Organisation, India; AIDS Society of India; Canadian AIDS Society, Canada; Southern African HIV Clinicians Society, South Africa. DESIRE Society Inc, United States.

Track 4: HIV/Viral Hepatitis

Hepatitis means inflammation of the liver. This condition is most often caused by a virus. The most common causes of viral hepatitis are hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV). HBV and HCV are common among people who are at risk for, or living with, HIV. You can get some forms of viral hepatitis the same way you get HIV—through unprotected sexual contact and injection drug use. HAV, which causes a short-term but occasionally severe illness, is usually spread when the virus is ingested from contact with food, drinks, or objects (including injection drug equipment), contaminated by feces (or stool) of an infected person.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: AIDS Research Institute, San Francisco, CA; International AIDS Society, Switzerland; National AIDS Commission of Belize, Belize; St. Maarten AIDS Foundation, Cole; UNAIDS, Switzerland; HIV.gov, Washington; HIV Medicine Association, Arlington; BHIVA, UK; National Association of People Living With HIV/AIDS, South Africa; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; American Sexual Health Association, North Carolina; National AIDS Control Organisation, India; AIDS Society of India; Canadian AIDS Society, Canada; Southern African HIV Clinicians Society, South Africa. DESIRE Society Inc, United States.

Track 5: Paediatric HIV Treatment Initiative

Human Immunodeficiency Virus (HIV) infection was identified the number of children infected with HIV has risen dramatically in developing countries, the result of an increased number of HIV-infected women of childbearing age in these areas. HIV is a retrovirus and can be transmitted vertically, sexually, or via contaminated blood products or IV drug abuse. Vertical HIV infection occurs before birth, during delivery, or after birth. Urgent Need to Develop and Deliver Antiretroviral Treatment Formulations for Infants and Children with HIV/AIDS.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: Related Societies and Associations: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; American Sexual Health Association, North Carolina; National AIDS Control Organisation, India; AIDS Society of India; Canadian AIDS Society, Canada; Southern African HIV Clinicians Society, South Africa. DESIRE Society Inc, United States. UNAIDS, Switzerland.

Track 6: Programs in biological Retro virology

Retroviruses are pleiotropically found in animals. Well-described examples include avian, murine and primate retroviruses. Two human retroviruses are especially important pathogens. These are the HIV and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-I is the etiological agent for adult T-cell leukemia. There is a large amount of basic research being conducted on HIV and HTLV-I spanning gene expression, virus structure-assembly, integration, replication, and pathogenesis. Retro virology intends to cover these areas of human and animal retrovirus research.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: AIDS Research Institute, San Francisco, CA; International AIDS Society, Switzerland; National AIDS Commission of Belize, Belize; St. Maarten AIDS Foundation, Cole; HIV.gov, Washington; HIV Medicine Association, Arlington; National Association of People Living With HIV/AIDS, South Africa; BHIVA, UK.

Track 7: Epidemiology of HIV infection

·         Risk factors for acquisition, infectivity, progression and transmission of HIV

·         Epidemiology of opportunistic infections and co-infections

·         Molecular epidemiology

·         Diagnosis of HIV infection (detection of acute and recent HIV infection, including self-testing)

·         Population-based surveys with HIV testing and viral load in epidemiology studies

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; American Sexual Health Association, North Carolina; National AIDS Control Organisation, India; AIDS Society of India; Canadian AIDS Society, Canada; Southern African HIV Clinicians Society, South Africa. DESIRE Society Inc, United States. UNAIDS, Switzerland.

Track 8:Immune Responses

The Immune system is composed of cells, organs, and proteins that work together to protect the body from viruses, bacteria, and other invaders. The immune response is the way in which your body recognizes and defends itself against bacteria, viruses, and other substances that are foreign and harmful. It is the job of the immune system to protect our bodies from harmful invaders by recognizing and responding to antigens. Typically proteins, antigens reside of the surface of cells, viruses, fungi, or bacteria, but antigens also may be non-living substances including toxins, chemicals, drugs, and foreign particles like splinters. The immune system remembers, recognizes, and destroys antigen-containing substances.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: AIDS Research Institute, San Francisco, CA; International AIDS Society, Switzerland; National AIDS Commission of Belize, Belize; St. Maarten AIDS Foundation, Cole; HIV.gov, Washington; HIV Medicine Association, Arlington; National Association of People Living With HIV/AIDS, South Africa; BHIVA, UK.

Track 9: Super and Co-Infections

Co-infections or super-infections with a non-hepatitis virus are also possible, and for HIV population, it is quite common due to the similarities of the infection route. (About 40% of patients with HIV are co-infected with HCV.) For these conditions, the clinical symptoms and disease courses are usually more complex and serious than a single viral infection case.

Although super or co-infections can make the disease more severe and its progression faster, there is also the possibility that one of the agents, such as HCV, could help promote the clearings of the other virus, such as HBV, from the body. HCV could also take over the position of HBV and become the major virus to cause persistent chronic infection.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Societies and Associations: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; American Sexual Health Association, North Carolina; National AIDS Control Organisation, India; AIDS Society of India; Canadian AIDS Society, Canada; Southern African HIV Clinicians Society, South Africa. DESIRE Society Inc, United States. UNAIDS, Switzerland.

Track 10:Diagnostic Tools for Immunological and Virological Monitoring of HIV Infection

Diagnosis of HIV infection can be carried out by detecting any of the following test Antibodies to HIV, P24 HIV antigen and HIV nucleic acid (RNA/DNA). The most commonly used method for the diagnosis of HIV infection is detection of anti-HIV antibodies in serum/plasma. It is economical, rapid and can be performed easily in most laboratories. HIV antibody assays are now commercially available in various formats. It is necessary to differentiate between HIV-1 and HIV-2 infections as the treatment varies for the two types. HIV-2 is intrinsically resistant to NNRTI drugs.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: AIDS Research Institute, San Francisco, CA; International AIDS Society, Switzerland; National AIDS Commission of Belize, Belize; St. Maarten AIDS Foundation, Cole; HIV.gov, Washington; HIV Medicine Association, Arlington; National Association of People Living With HIV/AIDS, South Africa; BHIVA, UK.

Track 11: Immunology of HIV/AIDS, STDs & STIs

Adults with immunodeficiencies are much more likely to suffer from molluscum contagiosum. Approximately 90% of patients who are HIV-positive have skin lesions of some sort, including molluscum contagiosum. In one study, 18% of patients who were HIV positive were found to have molluscum contagiosum (Rane et al., 2014).  Immunogenetics helps in understanding the pathogenesis of several autoimmune and infectious diseases and bacterial infections under clinical studies of STDs.

Related Conferences:

International Conference on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 4th World Congress on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; 6th International Congress on Bacteriology and Infectious Diseases May 25-26, 2018 New York, USA; 7th International Conference on Bacteriology and Infectious Diseases May 21-22, 2018 Osaka, Japan; 6th International Conference on Chronic Obstructive Pulmonary Disease May 17-18, 2018 Tokyo, Japan; 5th International congress on Infectious Diseases March 1-2, 2018 Berlin, Germany.

22nd International AIDS Conference, July 23-27, 2018 Amsterdam, Netherlands; 20th International Conference on HIV and AIDS, May 14 - 15, 2018 London, United Kingdom; 12th annual ACTHIV, April 5 - 7, 2018 Chicago, Illinois; 27th Annual Canadian Conference on HIV/AIDS Research, April 26-29, 2018 Vancouver, British Columbia; 9th edition of the International Francophone Conference on HIV/Hepatitis, April 4-7, 2018, Paris, France.

Related Societies and Associations: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; American Sexual Health Association, North Carolina; National AIDS Control Organisation, India; AIDS Society of India; Canadian AIDS Society, Canada; Southern African HIV Clinicians Society, South Africa. DESIRE Society Inc, United States. UNAIDS, Switzerland.

Past Conference Report

STD-HIV/AIDS 2017

STD-HIV/AIDS 2017

STD-HIV/AIDS 2017 Past Conference Report

5th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs (STD-HIV/AIDS 2017) organized by Conference Series LLC took place during June 19-20, 2017 at London, UK. The conference was organized around the theme “Creating New Wind to Prevent HIV/AIDS, STDs & STIs”.

 

Active participation and generous response was received from the Organizing Committee Members, Editorial Board Members of Journals as well as from Eminent Scientists, Talented Researchers and Young Student Community. All the support and cooperation from the Organizing Committee Members, Researchers and the Speakers had made STD-HIV/AIDS 2017 a successful event.

 

STD-HIV/AIDS 2017 Organizing Committee would like to thank the Honorable Guests for their generous support and suggestions:

 

·                     M Van Regenmortel, University of Strasbourg, France

·                     Kevin M Galalae, Center of Global Consciousness, Canada

 

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

 

·                     HIV Transmission and Viral Diversity

·                     Bacterial, Viral and Parasitic STDs & STIs

·                     HIV/AIDS, STDs & STIs

·                     Epidemiology of HIV/AIDS, STDs & STIs

·                     STD Symptoms: Common STDs and their Symptoms

·                     HIV/AIDS, STDs & STIs - Testing

·                     Prevention of Mother-to-Child Transmission

·                     STDs & Infertility

·                     Prevention &Treatment for Sexually Transmitted Infections

·                     Diagnosis of STDS

·                     Advanced Techniques in STDs

·                     Vaccine Development for STDS

·                     Outbreaks - HIV/AIDS, STDs & STIs

·                     Immunology of HIV/AIDS, STDs & STIs

·                     Control and Prevention of HIV/AIDS, STDs & STIs

·                     Public Awareness on STDS

·                     Entrepreneurs Investment Summit

 

The conference proceedings were carried out through various scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

 

·         “Reverse vaccinology cannot solve the inverse problem of developing an HIV vaccine” given by M Van Regenmortel, University of Strasbourg, France

·         “Increase fear to decrease growth: Strategies of population control in an over populated world” delivered by Kevin M Galalae, Center of Global Consciousness, Canada

·         “Predictors of sexual scripts among young, sexually-active, substance-using African American women”delivered by Mandy J Hill, University of TX Health, USA

 

Conference Series LLC would like to thank the Conference Sessions Chair Mandy J Hill, University of TX Health, USA who contributed a lot for the smooth functioning of this event.

 

Conference Series LLC has taken the privilege of felicitating STD-HIV/AIDS 2017 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. The esteemed Guests, Keynote Speakers, well-known Researchers and Delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand STD-HIV/AIDS 2017. We are glad to inform that all accepted abstracts for the conference have been published in Conference Series LLC Journal of AIDS & Clinical Research as a special issue.

 

We are also obliged to various Delegate Experts, Company Representatives and other Eminent Personalities who supported the conference by facilitating active discussion forums. With the unique feedback from the event, Conference Series LLC would like to announce the commencement of the “6th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs” to be held during July 2-3, 2018 in Vienna, Austria.

 

For more information please visit: http://std.conferenceseries.com/

 

Past Reports  Gallery  

Supported By

Journal of AIDS and Clinical Research Journal of Tropical Diseases & Public Health Journal of Infectious Diseases and Therapy Journal of Antivirals and Antiretrovirals

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by